4.8 Article

Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 341, Issue -, Pages 605-615

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2021.12.005

Keywords

Focused ultrasound; Liposomes; Blood-brain barrier; Brain drug delivery; Microbubbles; Neurons

Funding

  1. Alzheimer's Research UK [ARUKIRG2017A-7]
  2. King's College London
  3. Imperial College London EPSRC Centre for Doctoral Training in Medical Imaging [EP/L015226/1]
  4. EPSRC Centre for Neurotechnology [EP/L016737/1]
  5. EPSRC programme [EP/S032789/1, EP/R045046/1]
  6. Wellcome Trust [104931/ZS/14/Z]
  7. BBSRC [BB/L015129/1]
  8. Wellcome Trust Multiuser Equipment Grant [212885/Z/18/Z]
  9. Wellcome/EPSRC Centre for Medical Engineering [WT/203148/Z/16/Z]
  10. KCL and UCL Comprehensive Cancer Imaging Centre - CRUK
  11. EPSRC in association
  12. MRC
  13. DoH (England)
  14. National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust
  15. KCL [IS-BRC-1215-20006]
  16. EPSRC [EP/S032789/1, EP/R045046/1] Funding Source: UKRI

Ask authors/readers for more resources

The study investigates a noninvasive method of using ultrasound pulses to deliver liposomes across the blood-brain barrier for efficient drug delivery to the brain.
Liposomes are clinically used drug carriers designed to improve the delivery of drugs to specific tissues while minimising systemic distribution. However, liposomes are unable to cross the blood-brain barrier (BBB) and enter the brain, mostly due to their large size (ca. 100 nm). A noninvasive and localised method of delivering liposomes across the BBB is to intravenously inject microbubbles and apply long pulses of ultrasound (pulse length: >1 ms) to a targeted brain region. Recently, we have shown that applying rapid short pulses (RaSP) (pulse length: 5 ris) can deliver drugs with an improved efficacy and safety profile. However, this was tested with a relatively smaller 3-kDa molecule (dextran). In this study, we examine whether RaSP can deliver liposomes to the murine brain in vivo. Fluorescent DiDPEGylated liposomes were synthesized and injected intravenously alongside microbubbles. The left hippocampus of mice was then sonicated with either a RaSP sequence (5 ris at 1.25 kHz in groups of 10 ms at 0.5 Hz) or a long pulse sequence (10 ms at 0.5 Hz), with each pulse having a 1-MHz centre frequency (0.35 and 0.53 MPa). The delivery and distribution of the fluorescently-labelled liposomes were assessed by fluorescence imaging of the brain sections. The safety profile of the sonicated brains was assessed by histological staining. RaSP was shown to locally deliver liposomes across the BBB at 0.53 MPa with a more diffused and safer profile compared to the long pulse ultrasound sequence. Cellular uptake of liposomes was observed in neurons and microglia, while no uptake within astrocytes was observed in both RaSP and long pulse-treated brains. This study shows that RaSP allows a targeted and safe delivery of liposomal drugs into the murine brain with potential to deliver drugs into neuronal and glial targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available